These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7483494)

  • 1. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn.
    Vox Sang; 1995; 69(1):61-9. PubMed ID: 7483494
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody dependent cell mediated cytotoxicity and erythrophagocytosis assays in Rh haemolytic disease of the newborn.
    Patil JS; Gupte SC
    Ceylon Med J; 1996 Jun; 41(2):46-50. PubMed ID: 8771942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization.
    Oepkes D; van Kamp IL; Simon MJ; Mesman J; Overbeeke MA; Kanhai HH
    Am J Obstet Gynecol; 2001 Apr; 184(5):1015-20. PubMed ID: 11303214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two neonates with severe rhesus antagonism inspite of low values in recent tests of antibody dependent cellular cytotoxicity (ADCC)].
    Janssens LP; Koolen AM; Oei SG; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1823-6. PubMed ID: 10526587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion medicine illustrated: blocked D phenomenon.
    Moiz B; Salman M; Kamran N; Shamsuddin N
    Transfusion; 2008 Aug; 48(8):1545-6. PubMed ID: 18713103
    [No Abstract]   [Full Text] [Related]  

  • 7. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
    Lockyer WJ
    Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infection risk factors in newborn infants with fetal erythroblastosis].
    Maszkiewicz W; Ornat K; Laskowska B; Irzyńska D; Manerowska D
    Acta Haematol Pol; 1988; 19(3-4):230-8. PubMed ID: 3150899
    [No Abstract]   [Full Text] [Related]  

  • 10. The story of the Winnipeg Rh laboratory.
    Chown B
    J Lancet; 1967 Feb; 87(2):38-40. PubMed ID: 4963087
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay.
    Urbaniak SJ; Greiss MA; Crawford RJ; Fergusson MJ
    Vox Sang; 1984; 46(5):323-9. PubMed ID: 6730428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assays to predict the severity of hemolytic disease of the newborn.
    Hadley AG
    Transfus Med Rev; 1995 Oct; 9(4):302-13. PubMed ID: 8541713
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
    Dhingra-Kumar N; Duguid JK; Bromilow IM
    Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG subclasses of anti-Rh(D) and haemolytic disease of the newborn.
    Eklund J; Jouppila P; Seppälä IJ
    Vox Sang; 1988; 55(1):51-2. PubMed ID: 3138818
    [No Abstract]   [Full Text] [Related]  

  • 15. The ability of cellular assays to predict the necessity for cordocenteses in pregnancies at risk of haemolytic disease of the newborn.
    Zupańska B; Lenkiewicz B; Michalewska B; Rokicki T
    Vox Sang; 2001 May; 80(4):234. PubMed ID: 11438032
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is rhesus prophylaxis indicated also with positive antibodies?].
    Behrens O
    Z Geburtshilfe Neonatol; 1996; 200(6):246. PubMed ID: 9081755
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 19. The nonreactive nonstress test: predictive value for neonatal anemia in the isoimmunized pregnancy.
    Ouzounian JG; Alsulyman OM; Monteiro HA; Songster GS
    Obstet Gynecol; 1996 Sep; 88(3):364-7. PubMed ID: 8752240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.